@article{478361fb46c645abbee1efc1381d716d,
title = "Clinical Relevance of Standardized Mobile Gait Tests. Reliability Analysis between Gait Recordings at Hospital and Home in Parkinson's Disease: A Pilot Study",
abstract = "Background: Gait impairments in Parkinson's disease (PD) are quantified using inertial sensors under standardized test settings in the hospital. Recent studies focused on the assessment of free-living gait in PD. However, the clinical relevance of standardized gait tests recorded at the patient's home is unclear. Objective: To evaluate the reliability of supervised, standardized sensor-based gait outcomes at home compared to the hospital. Methods: Patients with PD (n=20) were rated by a trained investigator using the Unified Parkinson Disease Rating Scale (UPDRS-III). Gait tests included a standardized 4×10m walk test and the Timed Up and Go Test (TUG). Tests were performed in the hospital (HOSPITAL) and at patients' home (HOME), and controlled for investigator, time of the day, and medication. Statistics included reliability analysis using Intra-Class correlations and Bland-Altman plots. Results: UPDRS-III and TUG were comparable between HOSPITAL and HOME. PD patients' gait at HOME was slower (gait velocity Δ=-0.07±0.11m/s, -6.1%), strides were shorter (stride length Δ=-9.2±9.4cm; -7.3%), and shuffling of gait was more present (maximum toe-clearance Δ=-0.7±2.5cm; -8.8%). Particularly, narrow walkways (<85cm) resulted in a significant reduction of gait velocity at home. Reliability analysis (HOSPITAL vs. HOME) revealed excellent ICC coefficients for UPDRS-III (0.950, p<0.000) and gait parameters (e.g., stride length: 0.898, p<0.000; gait velocity: 0.914, p<0.000; stance time: 0.922, p<0.000; stride time: 0.907, p<0.000). Conclusion: This pilot study underlined the clinical relevance of gait parameters by showing excellent reliability for supervised, standardized gait tests at HOSPITAL and HOME, even though gait parameters were different between test conditions. ",
keywords = "gait analysis, home monitoring, Parkinson's disease, telemedicine, wearable sensors",
author = "Heiko Ga{\ss}ner and Philipp Sanders and Alisa DIetrich and Franz Marxreiter and Eskofier, {Bjoern M.} and J{\"u}rgen Winkler and Jochen Klucken",
note = "Funding Information: HG, BE, and JK are supported by Mobilise-D from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 820820. They further received an institutional research grant from the Bavarian Ministry of Economic Affairs and Media, Energy and Technology, Germany (Medical Valley Award 2016, Fall Risk PD). Funding Information: HG and FM received an institutional research grant by the Huntington-Stiftung of the Deutsche Huntington Hilfe e.V. Funding Information: BE holds ownerships of Portabiles HealthCare Technologies GmbH and Portabiles GmbH, received compensation and honoraria from serving on scientific advisory boards for Abbvie GmbH, Adidas GmbH, Bosch Sensortec GmbH, and ST Sportser-vice GmbH. Further, he gratefully acknowledges the support of the German Research Foundation (DFG) within the framework of the Heisenberg professorship programme (grant number ES 434/8-1). Funding Information: HG and JW received an institutional research grant by the Federal Ministry of Education and Research (project: treatHSP, grant number 01GM1905). HG further received support by the Manfred Roth-Stiftung, Forschungsstiftung Medizin am Uni-versit{\"a}tsklinikum Erlangen and the F{\"o}rderverein f{\"u}r HSP-Forschung e.V. Funding Information: FM is supported by the Interdisciplinary Center for Clinical Research of the FAU, Clinician Scientist programme. Funding Information: The authors would like to thank all patients that participated in this study. The study was supported by the Bavarian Ministry of Economic Affairs, Regional Development and Energy, and performed at the Department of Molecular Neurology (University Hospital Erlangen, Erlangen, Germany). The present work is part of the doctoral thesis of Philipp Sanders in the frame of obtaining the degree “Dr. med.” at the Medical Faculty, Friedrich-Alexander University Erlangen-N{\"u}rnberg (FAU). Heiko Ga{\ss}ner, This study has been approved by the local ethics committee in Erlangen, Germany and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Publisher Copyright: {\textcopyright} 2020 - IOS Press and the authors. All rights reserved.",
year = "2020",
doi = "10.3233/JPD-202129",
language = "English",
volume = "10",
pages = "1763--1773",
journal = "Journal of Parkinson's Disease",
issn = "1877-7171",
publisher = "IOS Press BV",
number = "4",
}